Recombinant Mouse Tigit, His tagged
Cat.No. : | Tigit-2348M |
Product Overview : | Recombinant Mouse Tigit (NP_001139797.1) extracellular domain (Met 1-Gly 141), fused with a C-terminal polyhistidine tag, was produced in Human Cell. |
Unit | |
Price | |
Qty |
- Specification
- Gene Information
- Related Products
Source : | Human Cells |
Species : | Mouse |
Tag : | His |
Form : | Lyophilized from sterile PBS, pH 7.4 |
Molecular Mass : | The secreted recombinant mouse TIGIT comprises 127 amino acids and has a calculated molecular mass of 14.2 kDa. As a result of glycosylation, the apparent molecular mass of rmSIRPA is approximately 20-25 kDa in SDS-PAGE under reducing conditions. |
Endotoxin : | < 1.0 eu per μg of the protein as determined by the LAL method. |
Stability : | Samples are stable for up to twelve months from date of receipt at -70oC. |
Storage : | Store it under sterile conditions at -20oC~-70oC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
Reconstitution : | It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4℃ before opening to recover the entire contents. |
Gene Name : | Tigit T cell immunoreceptor with Ig and ITIM domains [ Mus musculus ] |
Official Symbol : | Tigit |
Gene ID : | 100043314 |
mRNA Refseq : | NM_001146325 |
Protein Refseq : | NP_001139797 |
Products Types
◆ Recombinant Protein | ||
TIGIT-726C | Recombinant Cynomolgus monkey TIGIT Protein, Fc-tagged | +Inquiry |
TIGIT-733R | Recombinant Rat TIGIT Protein, Fc-tagged | +Inquiry |
TIGIT-0802R | Active Recombinant Rat TIGIT protein(Met1-Ala138), hFc-tagged | +Inquiry |
TIGIT-454H | Active Recombinant Human TIGIT protein(Met1-Pro141), hFc-tagged | +Inquiry |
TIGIT-1089H | Recombinant Human TIGIT protein(Met22 - Pro141), His-tagged | +Inquiry |
◆ Lysates | ||
TIGIT-2610HCL | Recombinant Human TIGIT cell lysate | +Inquiry |
TIGIT-1420MCL | Recombinant Mouse TIGIT cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionTIGIT inhibitors are being studied in a range of cancers, including lung cancer, breast cancer, and melanoma, among others.
TIGIT is being explored as a potential target for treating autoimmune diseases by modulating immune responses to prevent excessive inflammation.
TIGIT is being explored as a potential target for cancer immunotherapy, with drugs designed to block TIGIT and enhance the immune system's ability to attack cancer cells.
TIGIT operates as an immune checkpoint, similar to PD-1 and CTLA-4, but it has distinct mechanisms of action and may regulate different aspects of the immune response.
As with any immunotherapy, potential side effects may include immune-related adverse events such as inflammation in various organs, but the specific profile is still under investigation.
Customer Reviews (3)
Write a reviewWith its well-characterized nature and availability in various formats, the TIGIT protein is an advantageous tool that aids researchers in achieving their scientific goals.
Whether it's troubleshooting issues, optimizing experimental protocols, or providing detailed information about the protein, the manufacturer's support team is dedicated to helping researchers overcome any challenges they may encounter.
The manufacturer also ensures that the TIGIT protein is well-characterized, with extensive documentation on its functional properties.
Ask a Question for All Tigit Products
Required fields are marked with *
My Review for All Tigit Products
Required fields are marked with *
Inquiry Basket